Videos

Common Strategies to Manage Advanced Parkinson Disease

The acute care nurse practitioner at Overlook Medical Center discussed the presentation she gave at the Atlantic Health Stroke Symposium on the care of the hemorrhagic stroke in the neuro-ICU setting.

Adolfo Ramirez-Zamora, MD ;Joohi Jimenez-Shahed, MD ;Aristide Merola, MD, PhD ;Michael J. Soileau, MD

Advanced Parkinson Disease: Discussions With the Patient

Experts discuss different strategies to manage concerns relating to advanced Parkinson disease including patient education.

Adolfo Ramirez-Zamora, MD ;Joohi Jimenez-Shahed, MD ;Aristide Merola, MD, PhD ;Michael J. Soileau, MD

Transitioning Into Adulthood With Dravet Syndrome

A discussion about how to educate and speak with patients with advanced Parkinson disease.

Joseph Sullivan, MD;Trevor J. Resnick, MD;Elizabeth A. Thiele MD, PhD;Elaine C. Wirrell, MD

Impact of Dravet Syndrome on the Caregiver and Family

Elaine Wirrell, MD, reviews the transition of care into adulthood of patients with Dravet syndrome and how this transition can affect the patient, caregiver, and care provider.

Joseph Sullivan, MD;Trevor J. Resnick, MD;Elizabeth A. Thiele MD, PhD;Elaine C. Wirrell, MD

Apitegromab’s Potential in Treating SMA: Yung Chyung, MD

The panel discusses the impact on the family, siblings, or caregivers of patients with Dravet syndrome.

Yung Chyung, MD

July 5th 2021

Improving Use of Telemedicine in Minority Communities: Aarushi Suneja, MD; Zubair Ahmed, MD

The chief medical officer of Scholar Rock discussed topline results from the phase 2 TOPAZ study of apitegromab in patients with spinal muscular atrophy.

Zubair Ahmed, MD;Aarushi Suneja, MD

July 4th 2021

Lemborexant Shows Positive Medication Effect, New Comparative Study for CGRPs Announced, Ultra-Early Epilepsy Surgery Effective

The duo from Cleveland Clinic discussed their presentation from AHS 2021 regarding the effects of COVID-19 on access to telemedicine visits among minorities.

NeurologyLive® Staff

July 3rd 2021

Lifestyle Adjustments to Manage Pediatric Migraine: Valentina Popova, MD

Neurology News Network for the week ending July 2, 2021.

Valentina Popova, MD

July 1st 2021

Next Steps in Alzheimer Disease Research: Clive Ballard, MD

The pediatric headache specialist at NYU Langone discussed the lifestyle choices children and parents must make to ensure optimal management of pediatric migraine.

Clive Ballard, MD

July 1st 2021

Treatment Strategy for Relapsing MS

Clive Ballard, MD, discussed up-and-coming technologies for remote risk assessment, among other data presented at this year’s AAIC meeting.

Fred D. Lublin, MD;Ravi Dukkipati, MD;Gavin Giovannoni, MBBCh, PhD, FCP, FRCP, FRCPath;Lauren Gluck, MD

Family Planning and Behavior Issues Associated with Dravet Syndrome

Experts in multiple sclerosis (MS) provide an overview of treatment strategies and selection in relapsing MS.

Joseph Sullivan, MD;Elaine C. Wirrell, MD

The Diagnosis of Multiple Sclerosis

Considerations of genetic testing regarding family planning as well as behavioral issues associated with Dravet syndrome.

Fred D. Lublin, MD;Ravi Dukkipati, MD;Gavin Giovannoni, MBBCh, PhD, FCP, FRCP, FRCPath;Lauren Gluck, MD

Improving the Medical Education System via an Analytical Approach: Fabio Nascimento, MD

Fred D. Lublin, MD discusses the diagnosis of multiple sclerosis and the 2017 revisions of the McDonald criteria.

Fábio A Nascimento, MD

Dravet Syndrome: SUDEP and Increase Risk of Premature Mortality

The clinical fellow at Massachusetts General Hospital discussed his approach to highlighting flaws within the medical education system and the need to do so for certain areas in epilepsy.

Joseph Sullivan, MD;Elaine C. Wirrell, MD

Recognizing Advanced Parkinson Disease

Elaine C. Wirrell, MD, explains the increased risk of sudden unexpected death in epilepsy (SUDEP) in patients with Dravet syndrome and how to talk about it with caregivers and families.

Adolfo Ramirez-Zamora, MD ;Joohi Jimenez-Shahed, MD ;Aristide Merola, MD, PhD ;Michael J. Soileau, MD

Targeted Therapies for SMA Management: Nusinersen

Michael J. Soileau, MD, discusses how to recognize when a patient has advanced Parkinson disease, what are the initial or relevant signs and symptoms of advanced disease, and how patients shift from early to intermediate and advanced disease.

John F. Brandsema, MD;Julie Parsons, MD

Progression of Advanced Parkinson Disease

John Brandsema, MD, and Julie Parsons, MD, discuss the approval of nusinersen for the treatment of spinal muscular atrophy and their personal experiences regarding drug safety and administration in patients.

Adolfo Ramirez-Zamora, MD ;Joohi Jimenez-Shahed, MD ;Aristide Merola, MD, PhD ;Michael J. Soileau, MD

Early Referral to Neurologists for SMA Diagnosis

Joohi Jimenez-Shahed, MD, describes the natural progression of Parkinson disease from the time of diagnosis to advanced disease.

John F. Brandsema, MD;Julie Parsons, MD

AHS 2021 Takeaways and the State of Migraine Research: Richard B. Lipton, MD

Expert pediatric neurologists review the importance of early recognition and referral to neurologists for the diagnosis of spinal muscular atrophy and when it’s appropriate to approach treatment.

Richard B. Lipton, MD

Public, Private Sector Collaboration Essential to Aducanumab's Success in Alzheimer Disease: Ian Kremer, LEAD Coalition

The director of the Montefiore Headache Center discussed the momentum within the migraine research community as well as some of the more notable presentations from AHS 2021.

Ian Kremer

June 28th 2021

Raising Awareness for Pediatric Migraine: Valentina Popova, MD

The executive director of the LEAD Coalition calls for greater collaboration and support from government and the healthcare community in order to boost health equity.

Valentina Popova, MD

June 27th 2021

Clinical Takeaways From INP104 Data in Migraine: Sheena K. Aurora, MD

The pediatric headache specialist at NYU Langone discussed what physicians should be aware of related to the signs and symptoms associated with pediatric migraine.

Sheena K. Aurora, MD

June 26th 2021

Eptinezumab Demonstrates Rapid Relief, Zolgensma Improves Motor Function in SMA, RELIEF Study Results

The vice president of Medical Affairs in Migraine at Impel discussed the clinical takeaways from the STOP 301 trial of intranasal DHE and the advantages that the novel formulation might offer patients with migraine.

NeurologyLive® Staff

June 26th 2021

Fenfluramine as a Treatment Option for Dravet Syndrome

Neurology News Network for the week ending June 26, 2021.

Joseph Sullivan, MD;Trevor J. Resnick, MD;Elizabeth A. Thiele MD, PhD;Elaine C. Wirrell, MD

June 25th 2021

Cannabidiol as a Treatment Option for Dravet Syndrome

Elaine Wirrell, MD, provides background on fenfluramine, results from 2 clinical trials, and compares it to other treatment therapies.

Joseph Sullivan, MD;Trevor J. Resnick, MD;Elizabeth A. Thiele MD, PhD;Elaine C. Wirrell, MD

June 25th 2021

Trial-and-Error Approach With Aducanumab: Hermona Soreq, PhD

Elizabeth Thiele, MD, PhD, reviews cannabidiol oral solution as treatment of seizures associated with Dravet syndrome and the safety profile and dosing associated with it.

Hermona Soreq, PhD

June 25th 2021

Identifying Gaps in Trainee SUDEP Knowledge: Fabio Nascimento, MD

The professor of Molecular Neuroscience at the Edmond and Lily Safra Center for Brain Sciences provided thoughts on the comfortability of prescribing aducanumab knowing its safety profile.

Fábio A Nascimento, MD

June 24th 2021

Advantages and Safety Profile of INP104: Sheena K. Aurora, MD

The clinical fellow at Massachusetts General Hospital discussed the basis of his study evaluating adult neurology trainees and their familiarity with SUDEP and its risks.

Sheena K. Aurora, MD

June 23rd 2021